Home

Výchozí bod Který odpor anti a igg Předvečer Propojit Zhoubný

Anti Mouse/Rabbit IgG (H+L), made in horse, Biotinylated
Anti Mouse/Rabbit IgG (H+L), made in horse, Biotinylated

InVivoMAb polyclonal rat IgG | Bio X Cell
InVivoMAb polyclonal rat IgG | Bio X Cell

Mouse Anti-Rabbit IgG (Light-Chain Specific) (D4W3E) mAb (HRP Conjugate) |  Cell Signaling Technology
Mouse Anti-Rabbit IgG (Light-Chain Specific) (D4W3E) mAb (HRP Conjugate) | Cell Signaling Technology

PAb Anti Human IgG-d2 HTRF reagent | Cisbio
PAb Anti Human IgG-d2 HTRF reagent | Cisbio

Anti-A, Anti-B, Anti-A,B, Anti-D (IgG & IgM) Monoclonal Blood Grouping  Reagents Kit 4x10ml - Rapid Labs
Anti-A, Anti-B, Anti-A,B, Anti-D (IgG & IgM) Monoclonal Blood Grouping Reagents Kit 4x10ml - Rapid Labs

Anti Goat IgG (H+L), made in horse, Biotinylated x goat
Anti Goat IgG (H+L), made in horse, Biotinylated x goat

Donkey anti-Goat IgG (H+L) Cross-Adsorbed, Alexa Fluor™ 633 (A-21082)
Donkey anti-Goat IgG (H+L) Cross-Adsorbed, Alexa Fluor™ 633 (A-21082)

Human Anti-Influenza virus A IgG ELISA Kit (ab108745) | Abcam
Human Anti-Influenza virus A IgG ELISA Kit (ab108745) | Abcam

14-3-3 γ Protein (63A1) Anti-Human Mouse IgG MoAb, 10037-S | Monoclonal  Antibodies | IBL-America
14-3-3 γ Protein (63A1) Anti-Human Mouse IgG MoAb, 10037-S | Monoclonal Antibodies | IBL-America

Frontiers | ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B  Antibodies Are the Key Points
Frontiers | ABO Blood System and COVID-19 Susceptibility: Anti-A and Anti-B Antibodies Are the Key Points

Most of anti-glycolipid IgG-antibodies associated to neurological disorders  occur without their IgM counterpart | Journal of Biomedical Science | Full  Text
Most of anti-glycolipid IgG-antibodies associated to neurological disorders occur without their IgM counterpart | Journal of Biomedical Science | Full Text

Rabbit Anti Human Fibrinogen Polyclonal Fractionated – Innovative Research
Rabbit Anti Human Fibrinogen Polyclonal Fractionated – Innovative Research

Anti-D monoclonal antibodies from 23 human and rodent cell lines display  diverse IgG Fc-glycosylation profiles that determine their clinical  efficacy | Scientific Reports
Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy | Scientific Reports

HRP Goat Anti-Mouse IgG(H+L), Human Adsorbed | SouthernBiotech
HRP Goat Anti-Mouse IgG(H+L), Human Adsorbed | SouthernBiotech

Human IgG (H&L) Antibody DyLight™ 680 Conjugated Pre-Adsorbed (609-144-123)  | Rockland
Human IgG (H&L) Antibody DyLight™ 680 Conjugated Pre-Adsorbed (609-144-123) | Rockland

JCM | Free Full-Text | Lower Levels of ABO Anti-A and Anti-B of IgM, IgG  and IgA Isotypes in the Serum but Not the Saliva of COVID-19 Convalescents
JCM | Free Full-Text | Lower Levels of ABO Anti-A and Anti-B of IgM, IgG and IgA Isotypes in the Serum but Not the Saliva of COVID-19 Convalescents

Mapping the distribution of specific antibody interaction forces on  individual red blood cells | Scientific Reports
Mapping the distribution of specific antibody interaction forces on individual red blood cells | Scientific Reports

Goat anti-Rabbit IgG antibody (ABIN3020597)
Goat anti-Rabbit IgG antibody (ABIN3020597)

Anti‐A and anti‐B: what are they and where do they come from? - Branch -  2015 - Transfusion - Wiley Online Library
Anti‐A and anti‐B: what are they and where do they come from? - Branch - 2015 - Transfusion - Wiley Online Library

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland  (SEROCoV-POP): a population-based study - The Lancet
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study - The Lancet

Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG  Antibodies after COVID-19 mRNA BNT162b2 Vaccine
Diagnostics | Free Full-Text | Evaluation of Anti-SARS-Cov-2 S-RBD IgG Antibodies after COVID-19 mRNA BNT162b2 Vaccine

Anti-Human IgG (Green) | Lorne Laboratories UK
Anti-Human IgG (Green) | Lorne Laboratories UK

Complement activating ABO anti-A IgM/IgG act synergistically to cause  erythrophagocytosis: implications among minor ABO incompatible transfusions  | Journal of Translational Medicine | Full Text
Complement activating ABO anti-A IgM/IgG act synergistically to cause erythrophagocytosis: implications among minor ABO incompatible transfusions | Journal of Translational Medicine | Full Text

anti-Immunoglobulin G (IgG) secondary antibodies
anti-Immunoglobulin G (IgG) secondary antibodies